Adverse Childhood Experiences and Treatment-Resistant Depression: Why Early Life Matters More Than We Think


By Joao L. de Quevedo, MD, PhD, Director, Center for Interventional Psychiatry UTHealth Houston
March 23, 2026

When Depression Does Not Respond: Looking Back to Move Forward

Treatment-resistant depression (TRD) remains one of the most challenging conditions in psychiatry. Despite multiple evidence-based treatments, many patients continue to experience persistent symptoms, functional impairment, and increased risk of suicidality.

A recent large-scale study published in JAMA Network Open provides compelling evidence that adverse childhood experiences (ACEs) play a significant and independent role in the development of TRD, even after accounting for genetic and familial factors.

These findings reinforce a critical message:

👉 To understand treatment resistance, we must understand early life experiences.

What Are Adverse Childhood Experiences (ACEs)?

Adverse childhood experiences refer to traumatic or stressful events occurring before age 19, including:

  • Emotional neglect or abuse
  • Physical neglect or abuse
  • Sexual abuse or rape
  • Exposure to family violence
  • Hate crimes

ACEs are well-established risk factors for major depressive disorder, but their role in treatment resistance has remained less clear—until now.

A Powerful Study Design: Twins

This study analyzed data from more than 21,000 individuals in the Swedish Twin Registry, using a co-twin control design—one of the strongest methods available in observational research.

Why is this important?

Because twins share:

  • Genetics
  • Family environment
  • Early life context

By comparing twins with different levels of ACE exposure, researchers were able to isolate the impact of childhood adversity beyond shared familial factors.

Key Findings

ACEs Increase the Risk of Treatment-Resistant Depression

Each additional adverse childhood experience was associated with a 69% increase in the odds of TRD (OR 1.69).

Even more striking:

  • Individuals with any ACE had more than 3.5 times higher risk of TRD
  • Those with ≥3 ACEs had nearly a 7-fold increased risk

This demonstrates a clear dose-response relationship—the more adversity, the greater the risk.

The Association Persists Beyond Genetics

One of the most important findings is that the association remained significant even within the same family (OR 2.23).

This suggests that:

👉 ACEs are not just markers of genetic or family vulnerability

👉 They likely contribute directly to the development of treatment resistance

Not All ACEs Are Equal

Some types of adversity were particularly strongly associated with TRD:

  • Physical neglect → ~5.7-fold increased risk
  • Sexual abuse → ~5-fold increased risk

These findings highlight the especially profound impact of severe and interpersonal trauma on long-term mental health outcomes.

Stronger Association With TRD Than With Depression Overall

Importantly, ACEs showed a stronger association with treatment-resistant depression than with depression in general.

This suggests that ACEs may be particularly relevant in:

  • Identifying patients at risk for poor treatment response
  • Understanding why some patients do not improve despite adequate care

Why Do ACEs Lead to Treatment Resistance?

Several mechanisms may explain this association:

Biological Pathways

  • Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis
  • Increased inflammation
  • Altered neuroplasticity

Psychological Pathways

  • Reduced resilience
  • Maladaptive coping strategies
  • Increased sensitivity to stress

Clinical Implications

  • Reduced response to antidepressants
  • More chronic and recurrent illness

Together, these factors may create a more entrenched and biologically complex form of depression.

What This Means for Clinical Practice

This study has clear implications for how we evaluate and treat patients:

  1. Routine Assessment of ACEs

A careful history of early-life adversity should be part of every psychiatric evaluation, particularly in patients with difficult-to-treat depression.

2️. Earlier Identification of High-Risk Patients

Patients with significant ACE exposure may benefit from:

  • Earlier escalation of treatment
  • Use of interventional strategies (e.g., TMS, ECT, VNS, ketamine)
  • Closer monitoring and follow-up

3️. Trauma-Informed Care

Treatment approaches should incorporate:

  • Trauma-informed psychotherapy
  • Integrated biological and psychological strategies
  • Long-term care planning

4️. Prevention Matters

Perhaps the most important implication:

👉 Preventing adverse childhood experiences may reduce the burden of treatment-resistant depression in the future

Final Thoughts

This study represents one of the most rigorous demonstrations to date that early life adversity is a key driver of treatment-resistant depression.

For clinicians, it reinforces the need to move beyond symptom-based treatment and toward a lifespan, personalized model of care.

For patients, it offers validation that treatment resistance is not a failure—but often the result of deeply rooted biological and psychological processes shaped by early experiences.

And for society, it highlights a powerful opportunity:

👉 Investing in childhood well-being may be one of the most effective strategies for reducing the risk of severe mental illness later in life.

Reference

Xiong Y, Lindersten P, Gong T, Magnusson PKE, Liu S, Lu Y. Adverse Childhood Experiences and Treatment-Resistant Depression. JAMA Network Open. 2026;9(3):e260222.

Contact

Request for Second Opinion Form – https://Go.uth.edu/CIPIntake

Phone – (713) 486-2621

Fax – (713) 500-2728

E-mail – [email protected]

Website: https://go.uth.edu/CIP

Disclaimer

This article was created with the assistance of artificial intelligence (AI) to help organize and refine the presentation of scientific information. All medical and scientific content has been reviewed and approved by Joao L. de Quevedo, MD, PhD, Director of the Center for Interventional Psychiatry at the John S. Dunn Behavioral Sciences Center at UTHealth Houston. The content is intended for educational and informational purposes only and does not substitute for professional medical advice.